Results 191 to 200 of about 283,997 (324)

Impact on weight of a Doravirine switch in people living with HIV

open access: yesHIV Medicine, Volume 27, Issue 1, Page 136-145, January 2026.
Abstract Background and Objective Doravirine is among the first‐line recommended treatments for people living with HIV (PLHIV) in the 2025 EACS guidelines. As opposed to tenofovir alafenamide or anti‐integrase, its use was not associated with weight gain in clinical trials, but limited data are currently available in real life. In this cohort study, we
Nina Garofoli   +7 more
wiley   +1 more source

Resolving inflammation: The impact of antiretroviral therapy on macrophage traffic in and out of the CNS. [PDF]

open access: yesPLoS Pathog
Wallis ZK   +13 more
europepmc   +1 more source

Trained Immunity and Cardiovascular Risk: An Immunological Perspective

open access: yesImmunological Reviews, Volume 337, Issue 1, January 2026.
ABSTRACT Systemic inflammation is a key driver of atherogenesis and its complications. While anti‐inflammatory therapies targeting pathways such as IL‐1β and IL‐6 have shown promise in established atherosclerotic cardiovascular disease (ASCVD), potential systemic effects raise concerns about immune suppression and infection, underscoring the need for ...
Katherine A. Boden   +3 more
wiley   +1 more source

Combination antiretroviral therapy and the risk of myocardial infarction [PDF]

open access: yes, 2003
Abbadesse, V   +535 more
core  

Home - About - Disclaimer - Privacy